-+ 0.00%
-+ 0.00%
-+ 0.00%

USFDA closes inspection of Dr. Reddy's Bachupally plant with voluntary action indicated

PUBT·11/16/2026 11:26:38
Listen to the news
USFDA closes inspection of Dr. Reddy's Bachupally plant with voluntary action indicated
  • The USFDA classified its manufacturing-practices inspection of Dr. Reddy's FTO-3 formulations facility in Bachupally, Hyderabad, as “Voluntary Action Indicated.”
  • The inspection, disclosed on August 14, 2026, is officially closed.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dr. Reddy's Laboratories Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001575872-26-000790), on November 16, 2026, and is solely responsible for the information contained therein.